Global Extended Release Drug Industry Research Report 2020, Forecast to 2025

September 2020 | 100 pages | ID: GC7052263CF0EN
WKinformation

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The Extended Release Drug market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Extended Release Drug is projected to grow from US$ xx million in 2020, and is projected to reach xx by 2025, at a CAGR of xx% during the forecast period. Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation. Product values are estimated based on manufacturers' revenue.

The report offers detailed coverage of Extended Release Drug industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Extended Release Drug by geography. The report splits the market size, by volume and value, on the basis of application type and geography.

In addition to this data, the report provides insight into drivers of market demand and strategies of suppliers. Key players are profiled, and their market shares in the global Extended Release Drug market are discussed.

The market is segmented by types:

• Sustained Release Drug
• Controlled Release Drug

It can be also divided by applications:

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

And this report covers the historical situation, present status and the future prospects of the global Extended Release Drug market for 2015-2025. In this report, we analyze global market from 5 geographies: Asia-Pacific, Europe, North America, Middle East & Africa, South America.

Finally, the report provides detailed profile and data information analysis of leading company.

• Pfizer
• Hisamitsu Pharmaceutical
• Johnson & Johnson
• Mallinckrodt
• Mylan
• Teva
• Purdue Pharma
• Endo Pharmaceuticals
• Sun Pharmaceutical Industries

Report Includes:

• xx data tables and xx additional tables
• An overview of global Extended Release Drug market
• An detailed key players analysis across regions
• Analyses of global market trends, with historical data, estimates for 2020 and projections of compound annual growth rates (CAGRs) through 2025
• Insights into regulatory and environmental developments
• Information on the supply and demand scenario and evaluation of technological and investment opportunities in the Extended Release Drug market
• Profiles of major players in the industry, including Pfizer, Hisamitsu Pharmaceutical, Johnson & Johnson, Mallinckrodt, Mylan.....

Research Objectives

• To study and analyze the global Extended Release Drug consumption (value & volume) by key regions/countries, product type and application, history data from 2015 to 2019, and forecast to 2025.
• To understand the structure of Extended Release Drug market by identifying its various subsegments.
• Focuses on the key global Extended Release Drug manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
• To analyze the Extended Release Drug with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of Extended Release Drug submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

Global Extended Release Drug Market Report 2020, Forecast to 2025

1 SCOPE OF THE STUDY

1.1 Extended Release Drug Introduction
1.2 Research Programs
1.3 Analysis of Macroeconomic Indicators
1.4 Years Considered
1.5 Methodology
1.6 Data Source
1.7 Research Objectives

2 EXTENDED RELEASE DRUG INDUSTRY OVERVIEW

2.1 Global Extended Release Drug Market Size (Million USD) Comparison by Regions (2020-2025)
  2.1.1 Extended Release Drug Global Import Market Analysis
  2.1.2 Extended Release Drug Global Export Market Analysis
  2.1.3 Extended Release Drug Global Main Region Market Analysis
2.2 Market Analysis by Type
  2.2.1 Sustained Release Drug
  2.2.2 Controlled Release Drug
2.3 Market Analysis by Application
  2.3.1 Hospital Pharmacy
  2.3.2 Retail Pharmacy
  2.3.3 Online Pharmacy
2.4 Global Extended Release Drug Revenue, Sales and Market Share by Manufacturer
  2.4.1 Global Extended Release Drug Sales and Market Share by Manufacturer (2018-2020)
  2.4.2 Global Extended Release Drug Revenue and Market Share by Manufacturer (2018-2020)
  2.4.3 Global Extended Release Drug Industry Concentration Ratio (CR5 and HHI)
  2.4.4 Top 5 Extended Release Drug Manufacturer Market Share
  2.4.5 Top 10 Extended Release Drug Manufacturer Market Share
  2.4.6 Date of Key Manufacturers Enter into Extended Release Drug Market
  2.4.7 Key Manufacturers Extended Release Drug Product Offered
  2.4.8 Mergers & Acquisitions Planning
2.5 Extended Release Drug Historical Development Overview
2.6 Market Dynamics
  2.6.1 Market Opportunities
  2.6.2 Market Risk
  2.6.3 Market Driving Force
  2.6.4 Porter's Five Forces Analysis
2.7 Coronavirus Disease 2019 (Covid-19): Extended Release Drug Industry Impact
  2.7.1 How the Covid-19 is Affecting the Extended Release Drug Industry
  2.7.2 Extended Release Drug Business Impact Assessment - Covid-19
  2.7.3 Market Trends and Extended Release Drug Potential Opportunities in the COVID-19 Landscape
  2.7.4 Measures / Proposal against Covid-19

3 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS

3.1 Upstream Analysis
  3.1.1 Macro Analysis of Upstream Markets
  3.1.2 Key Players in Upstream Markets
  3.1.3 Upstream Market Trend Analysis
  3.1.4 Extended Release Drug Manufacturing Cost Analysis
3.2 Downstream Market Analysis
  3.2.1 Macro Analysis of Down Markets
  3.2.2 Key Players in Down Markets
  3.2.3 Downstream Market Trend Analysis
  3.2.4 Sales Channel, Distributors, Traders and Dealers

4 GLOBAL EXTENDED RELEASE DRUG MARKET SIZE CATEGORIZED BY REGIONS (2015-2020)

4.1 Global Extended Release Drug Sales Market Share by Region
4.2 Global Extended Release Drug Revenue Market Share by Region (2015-2019)
4.3 Global Extended Release Drug Sales, Revenue, Price and Gross Margin (2015-2020)
4.4 North America Extended Release Drug Market Size Detail
  4.4.1 North America Extended Release Drug Sales Growth Rate (2015-2020)
  4.4.2 North America Extended Release Drug Sales, Revenue, Price and Gross Margin (2015-2020)
4.5 Europe Extended Release Drug Market Size Detail
  4.5.1 Europe Extended Release Drug Sales Growth Rate (2015-2020)
  4.5.2 Europe Extended Release Drug Sales, Revenue, Price and Gross Margin (2015-2020)
4.6 Japan Extended Release Drug Market Size Detail
  4.6.1 Japan Extended Release Drug Sales Growth Rate (2015-2020)
  4.6.2 Japan Extended Release Drug Sales, Revenue, Price and Gross Margin (2015-2020)
4.7 China Extended Release Drug Market Size Detail
  4.7.1 China Extended Release Drug Sales Growth Rate (2015-2020)
  4.7.2 China Extended Release Drug Sales, Revenue, Price and Gross Margin (2015-2020)

5 GLOBAL EXTENDED RELEASE DRUG MARKET SEGMENT BY TYPE

5.1 Global Extended Release Drug Revenue, Sales and Market Share by Type (2015-2020)
  5.1.1 Global Extended Release Drug Sales and Market Share by Type (2015-2020)
  5.1.2 Global Extended Release Drug Revenue and Market Share by Type (2015-2020)
5.2 Sustained Release Drug Sales Growth Rate and Price
  5.2.1 Global Sustained Release Drug Sales Growth Rate (2015-2020)
  5.2.2 Global Sustained Release Drug Price (2015-2020)
5.3 Controlled Release Drug Sales Growth Rate and Price
  5.3.1 Global Controlled Release Drug Sales Growth Rate (2015-2020)
  5.3.2 Global Controlled Release Drug Price (2015-2020)

6 GLOBAL EXTENDED RELEASE DRUG MARKET SEGMENT BY APPLICATION

6.1 Global Extended Release DrugSales Market Share by Application (2015-2020)
6.2 Hospital Pharmacy Sales Growth Rate (2015-2020)
6.3 Retail Pharmacy Sales Growth Rate (2015-2020)
6.4 Online Pharmacy Sales Growth Rate (2015-2020)

7 GLOBAL EXTENDED RELEASE DRUG MARKET FORECAST

7.1 Global Extended Release Drug Sales, Revenue Forecast
  7.1.1 Global Extended Release Drug Sales Growth Rate Forecast (2020-2025)
  7.1.2 Global Extended Release Drug Revenue and Growth Rate Forecast (2020-2025)
  7.1.3 Global Extended Release Drug Price and Trend Forecast (2020-2025)
7.2 Global Extended Release Drug Sales Forecast by Region (2020-2025)
  7.2.1 North America Extended Release Drug Sales, Revenue Forecast (2020-2025)
  7.2.2 Europe Extended Release Drug Sales, Revenue Forecast (2020-2025)
  7.2.3 Japan Extended Release Drug Production, Revenue Forecast (2020-2025)
  7.2.4 China Extended Release Drug Production, Revenue Forecast (2020-2025)

8 ANALYSIS OF EXTENDED RELEASE DRUG INDUSTRY KEY MANUFACTURERS

8.1 Pfizer
  8.1.1 Company Details
  8.1.2 Product Information
  8.1.3 Pfizer Extended Release Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.1.4 Main Business Overview
  8.1.5 Pfizer News
8.2 Hisamitsu Pharmaceutical
  8.2.1 Company Details
  8.2.2 Product Information
  8.2.3 Hisamitsu Pharmaceutical Extended Release Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.2.4 Main Business Overview
  8.2.5 Hisamitsu Pharmaceutical News
8.3 Johnson & Johnson
  8.3.1 Company Details
  8.3.2 Product Information
  8.3.3 Johnson & Johnson Extended Release Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.3.4 Main Business Overview
  8.3.5 Johnson & Johnson News
8.4 Mallinckrodt
  8.4.1 Company Details
  8.4.2 Product Information
  8.4.3 Mallinckrodt Extended Release Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.4.4 Main Business Overview
  8.4.5 Mallinckrodt News
8.5 Mylan
  8.5.1 Company Details
  8.5.2 Product Information
  8.5.3 Mylan Extended Release Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.5.4 Main Business Overview
  8.5.5 Mylan News
8.6 Teva
  8.6.1 Company Details
  8.6.2 Product Information
  8.6.3 Teva Extended Release Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.6.4 Main Business Overview
  8.6.5 Teva News
8.7 Purdue Pharma
  8.7.1 Company Details
  8.7.2 Product Information
  8.7.3 Purdue Pharma Extended Release Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.7.4 Main Business Overview
  8.7.5 Purdue Pharma News
8.8 Endo Pharmaceuticals
  8.8.1 Company Details
  8.8.2 Product Information
  8.8.3 Endo Pharmaceuticals Extended Release Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.8.4 Main Business Overview
  8.8.5 Endo Pharmaceuticals News
8.9 Sun Pharmaceutical Industries
  8.9.1 Company Details
  8.9.2 Product Information
  8.9.3 Sun Pharmaceutical Industries Extended Release Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.9.4 Main Business Overview
  8.9.5 Sun Pharmaceutical Industries News

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Extended Release Drug Picture
Figure Research Programs/Design for This Report
Figure Global Extended Release Drug Market by Regions (2019)
Table Global Market Extended Release Drug Comparison by Regions (M USD) 2019-2025
Table Global Extended Release Drug Sales Growth (CAGR) (2019-2025) by Type
Figure Global Sales Market Share of Extended Release Drug by Type in 2019
Figure Sustained Release Drug Picture
Figure Controlled Release Drug Picture
Table Global Extended Release Drug Sales by Application (2019-2025)
Figure Global Extended Release Drug Sales Market Share by Application in 2019
Figure Hospital Pharmacy Picture
Figure Retail Pharmacy Picture
Figure Online Pharmacy Picture
Table Global Extended Release Drug Sales by Manufacturer (2018-2020)
Figure Global Extended Release Drug Sales Market Share by Manufacturer in 2019
Table Global Extended Release Drug Revenue by Manufacturer (2018-2020)
Figure Global Extended Release Drug Revenue Market Share by Manufacturer in 2019
Table Global Extended Release Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Extended Release Drug Manufacturer (Revenue) Market Share in 2019
Figure Top 10 Extended Release Drug Manufacturer (Revenue) Market Share in 2019
Table Date of Key Manufacturers Enter into Extended Release Drug Market
Table Key Manufacturers Extended Release Drug Product Type
Table Mergers & Acquisitions Planning
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Extended Release Drug
Table Key Players of Upstream Markets
Figure Sales Channel
Table Global Extended Release Drug Sales (K Units) by Region (2015-2020)
Table Global Extended Release Drug Sales Market Share by Region (2015-2019)
Figure Global Extended Release Drug Sales Market Share by Region (2015-2019)
Figure Global Extended Release Drug Sales Market Share by Region in 2018
Table Global Extended Release Drug Revenue (Million US$) by Region (2015-2020)
Table Global Extended Release Drug Revenue Market Share by Region (2015-2020)
Figure Global Extended Release Drug Revenue Market Share by Region (2015-2020)
Figure Global Extended Release Drug Revenue Market Share by Region in 2019
Table Global Extended Release Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure North America Extended Release Drug Sales (K Units) Growth Rate (2015-2020)
Table North America Extended Release Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Europe Extended Release Drug Sales (K Units) Growth Rate (2015-2020)
Table Europe Extended Release Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Japan Extended Release Drug Sales (K Units) Growth Rate (2015-2020)
Table Japan Extended Release Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure China Extended Release Drug Sales (K Units) Growth Rate (2015-2020)
Table China Extended Release Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table Global Extended Release Drug Sales by Type (2015-2020)
Table Global Extended Release Drug Sales Market Share by Type (2015-2020)
Figure Global Extended Release Drug Sales Market Share by Type in 2019
Table Global Extended Release Drug Revenue by Type (2015-2020)
Table Global Extended Release Drug Revenue Market Share by Type (2015-2020)
Figure Global Extended Release Drug Revenue Market Share by Type in 2019
Figure Global Sustained Release Drug Sales Growth Rate (2015-2020)
Figure Global Sustained Release Drug Price (2015-2020)
Figure Global Controlled Release Drug Sales Growth Rate (2015-2020)
Figure Global Controlled Release Drug Price (2015-2020)
Table Global Extended Release Drug Sales by Application (2015-2020)
Table Global Extended Release Drug Sales Market Share by Application (2015-2020)
Figure Global Extended Release Drug Sales Market Share by Application in 2019
Figure Global Hospital Pharmacy Sales Growth Rate (2015-2020)
Figure Global Retail Pharmacy Sales Growth Rate (2015-2020)
Figure Global Online Pharmacy Sales Growth Rate (2015-2020)
Figure Global Extended Release Drug Production (K Units) Growth Rate Forecast (2020-2025)
Figure Global Extended Release Drug Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Global Extended Release Drug Price and Trend Forecast (2020-2025)
Table Global Extended Release Drug Sales (K Units) Forecast by Region (2020-2025)
Figure Global Extended Release Drug Production Market Share Forecast by Region (2020-2025)
Figure North America Extended Release Drug Sales (K Units) Growth Rate Forecast (2020-2025)
Figure North America Extended Release Drug Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Europe Extended Release Drug Sales (K Units) Growth Rate Forecast (2020-2025)
Figure Europe Extended Release Drug Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Japan Extended Release Drug Production (K Units) Growth Rate Forecast (2020-2025)
Figure Japan Extended Release Drug Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure China Extended Release Drug Production (K Units) Growth Rate Forecast (2020-2025)
Figure China Extended Release Drug Revenue (Million US$) Growth Rate Forecast (2020-2025)
Table Pfizer Company Profile
Figure Extended Release Drug Product Picture and Specifications of Pfizer
Table Extended Release Drug Production, Price, Revenue and Gross Margin of 2018-2020
Figure Pfizer Extended Release Drug Market Share (2018-2020)
Table Pfizer Main Business
Table Pfizer Recent Development
Table Hisamitsu Pharmaceutical Company Profile
Figure Extended Release Drug Product Picture and Specifications of Hisamitsu Pharmaceutical
Table Extended Release Drug Production, Price, Revenue and Gross Margin of 2018-2020
Figure Hisamitsu Pharmaceutical Extended Release Drug Market Share (2018-2020)
Table Hisamitsu Pharmaceutical Main Business
Table Hisamitsu Pharmaceutical Recent Development
Table Johnson & Johnson Company Profile
Figure Extended Release Drug Product Picture and Specifications of Johnson & Johnson
Table Extended Release Drug Production, Price, Revenue and Gross Margin of 2018-2020
Figure Johnson & Johnson Extended Release Drug Market Share (2018-2020)
Table Johnson & Johnson Main Business
Table Johnson & Johnson Recent Development
Table Mallinckrodt Company Profile
Figure Extended Release Drug Product Picture and Specifications of Mallinckrodt
Table Extended Release Drug Production, Price, Revenue and Gross Margin of 2018-2020
Figure Mallinckrodt Extended Release Drug Market Share (2018-2020)
Table Mallinckrodt Main Business
Table Mallinckrodt Recent Development
Table Mylan Company Profile
Figure Extended Release Drug Product Picture and Specifications of Mylan
Table Extended Release Drug Production, Price, Revenue and Gross Margin of 2018-2020
Figure Mylan Extended Release Drug Market Share (2018-2020)
Table Mylan Main Business
Table Mylan Recent Development
Table Teva Company Profile
Figure Extended Release Drug Product Picture and Specifications of Teva
Table Extended Release Drug Production, Price, Revenue and Gross Margin of 2018-2020
Figure Teva Extended Release Drug Market Share (2018-2020)
Table Teva Main Business
Table Teva Recent Development
Table Purdue Pharma Company Profile
Figure Extended Release Drug Product Picture and Specifications of Purdue Pharma
Table Extended Release Drug Production, Price, Revenue and Gross Margin of 2018-2020
Figure Purdue Pharma Extended Release Drug Market Share (2018-2020)
Table Purdue Pharma Main Business
Table Purdue Pharma Recent Development
Table Endo Pharmaceuticals Company Profile
Figure Extended Release Drug Product Picture and Specifications of Endo Pharmaceuticals
Table Extended Release Drug Production, Price, Revenue and Gross Margin of 2018-2020
Figure Endo Pharmaceuticals Extended Release Drug Market Share (2018-2020)
Table Endo Pharmaceuticals Main Business
Table Endo Pharmaceuticals Recent Development
Table Sun Pharmaceutical Industries Company Profile
Figure Extended Release Drug Product Picture and Specifications of Sun Pharmaceutical Industries
Table Extended Release Drug Production, Price, Revenue and Gross Margin of 2018-2020
Figure Sun Pharmaceutical Industries Extended Release Drug Market Share (2018-2020)
Table Sun Pharmaceutical Industries Main Business
Table Sun Pharmaceutical Industries Recent Development
Table of Appendix